Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $174.16M | $9.40 | $39.00 | 314.89% | Strong Buy | 6 | N/A | N/A | -68.12% | -59.57% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $19.89M | $2.31 | $20.33 | 780.22% | Strong Buy | 3 | N/A | N/A | -4.32% | -3.47% | |||
| ALM | ALMONTY INDUSTRIES INC | $3.49B | $13.28 | $26.50 | 99.55% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| FTH | FAETH THERAPEUTICS INC | $34.22M | $25.50 | $55.44 | 117.43% | Strong Buy | 9 | N/A | N/A | N/A | -7.93% | |||
| OSTX | OS THERAPIES INC | $72.60M | $1.63 | $13.33 | 717.98% | Strong Buy | 3 | N/A | N/A | N/A | -31.12% | |||
| DSGN | DESIGN THERAPEUTICS INC | $826.08M | $13.20 | $16.67 | 26.27% | Strong Buy | 3 | N/A | N/A | -47.59% | -44.66% | |||
| VOR | VOR BIOPHARMA INC | $1.21B | $22.25 | $32.25 | 44.94% | Strong Buy | 4 | N/A | N/A | N/A | -18.65% | |||
| WHWK | WHITEHAWK THERAPEUTICS INC | $204.73M | $4.14 | $9.00 | 117.39% | Strong Buy | 3 | N/A | N/A | -48.19% | -44.01% | |||
| ASST | STRIVE INC | $907.69M | $12.42 | $27.60 | 122.22% | Strong Buy | 5 | N/A | N/A | 13.80% | 8.97% | |||
| LONA | LEONABIO INC | $71.95M | $7.66 | $16.00 | 108.88% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| BIOA | BIOAGE LABS INC | $497.87M | $11.20 | $47.50 | 324.11% | Strong Buy | 6 | 7.71% | N/A | -43.20% | -41.19% | |||
| BNTX | BIONTECH SE | $23.10B | $91.35 | $126.80 | 38.81% | Strong Buy | 10 | -7.32% | N/A | -4.59% | -4.07% | |||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $265.09M | $1.97 | $4.33 | 119.95% | Strong Buy | 3 | N/A | N/A | -62.57% | -53.11% | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $778.22M | $2.91 | $6.80 | 133.68% | Strong Buy | 7 | N/A | N/A | N/A | N/A | |||
| SKHY | SK HYNIX INC | N/A | $154.38 | $245.50 | 59.02% | Strong Buy | 8 | N/A | N/A | N/A | N/A | |||
| QNCX | QUINCE THERAPEUTICS INC | $22.34M | $27.41 | $80.67 | 194.30% | Strong Buy | 3 | N/A | N/A | -3.79% | -2.23% | |||
| DEFT | DEFI TECHNOLOGIES INC | $182.64M | $0.47 | $1.83 | 289.17% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| GT | GOODYEAR TIRE & RUBBER CO | $2.07B | $7.19 | $9.00 | 25.17% | Strong Buy | 4 | 2.13% | N/A | 16.46% | 2.68% | |||
| LTRX | LANTRONIX INC | $242.88M | $6.10 | $10.63 | 74.18% | Strong Buy | 4 | 13.04% | N/A | N/A | N/A | |||
| AVAV | AEROVIRONMENT INC | $8.55B | $169.02 | $226.07 | 33.75% | Strong Buy | 14 | 9.98% | N/A | 6.45% | 4.96% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $1.40B | $13.47 | $19.33 | 43.53% | Strong Buy | 3 | N/A | N/A | -48.75% | -45.93% | |||
| XE | X-ENERGY INC | $5.34B | $18.57 | $38.71 | 108.48% | Strong Buy | 7 | N/A | N/A | N/A | -7.92% | |||
| CPS | COOPER-STANDARD HOLDINGS INC | $546.15M | $30.76 | $51.22 | 66.51% | Strong Buy | 3 | 4.36% | N/A | -84.52% | 5.26% | |||
| SGP | SPYGLASS PHARMA INC | $806.08M | $24.11 | $45.00 | 86.64% | Strong Buy | 5 | N/A | N/A | -38.75% | -37.51% | |||
| VIA | VIA TRANSPORTATION INC | $1.78B | $21.91 | $40.75 | 85.99% | Strong Buy | 4 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.